The Management of HER2+ Breast Cancer: A Rapidly Changing Frontier

The Management of HER2+ Breast Cancer: A Rapidly Changing Frontier

0% Complete

Course Overview

NA

Course Content

Course Details

Duration
0.00 hour
Released
May 14, 2025
Last Review
May 14, 2025
Expires
May 14, 2028

Objectives

NA

Target Audience

NA

Faculty & Disclosure

Faculty

Jane Meisel, MD

Disclosure

Jane Meisel, MD discloses no such relationships exist

Accreditation

NA